Immunologic Aspects of Dyslipidemia: a Critical Regulator of Adaptive Immunity and Immune Disorders

Dyslipidemia is a major cause of cardiovascular diseases which represent a leading cause of death in humans. Diverse immune cells are known to be involved in the pathogenesis of cardiovascular diseases such as atherosclerosis. Conversely, dyslipidemia is known to be tightly associated with immune disorders in humans, as evidenced by a higher incidence of atherosclerosis in patients with autoimmune diseases including psoriasis, rheumatoid arthritis, and systemic lupus erythematosus. Given that the dyslipidemia-related autoimmune diseases are caused by autoreactive T cells and B cells, dyslipidemia seems to directly or indirectly regulate the adaptive immunity. Indeed, accumulating evidence has unveiled that proatherogenic factors can impact the differentiation and function of CD4+ T cells, CD8+ T cells, and B cells. This review discusses an updated overview on the regulation of adaptive immunity by dyslipidemia and proposes a potential therapeutic strategy for immune disorders by targeting lipid metabolism.

[1]  Nicole M. Chapman,et al.  Lipid signalling enforces Treg cell functional specialization in tumours , 2021, Nature.

[2]  A. Rudensky,et al.  Nuclear receptor LXRβ controls fitness and functionality of activated T cells , 2020, The Journal of experimental medicine.

[3]  L. Penn,et al.  Statins as Anticancer Agents in the Era of Precision Medicine , 2020, Clinical Cancer Research.

[4]  K. Okkenhaug,et al.  Cholesterol metabolism drives regulatory B cell IL-10 through provision of geranylgeranyl pyrophosphate , 2020, Nature Communications.

[5]  Ik Soo Kim,et al.  RORα Regulates Cholesterol Metabolism of CD8+ T Cells for Anticancer Immunity , 2020, Cancers.

[6]  W. Masson,et al.  Psoriasis and Cardiovascular Risk: A Comprehensive Review , 2020, Advances in Therapy.

[7]  J. Liao,et al.  Serine-threonine kinase, ROCK2, regulates germinal center B cell positioning and cholesterol biosynthesis. , 2020, The Journal of clinical investigation.

[8]  M. Weekes,et al.  Epstein-Barr virus subverts mevalonate and fatty acid pathways to promote infected B-cell proliferation and survival , 2019, PLoS pathogens.

[9]  I. Melero,et al.  Dendritic cells in cancer immunology and immunotherapy , 2019, Nature Reviews Immunology.

[10]  M. Kalady,et al.  Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment. , 2019, Cell metabolism.

[11]  Kevin A. Robertson,et al.  The cholesterol biosynthesis pathway regulates IL-10 expression in human Th1 cells , 2019, Nature Communications.

[12]  Andrea Reboldi,et al.  Cholesterol metabolism in innate and adaptive response , 2018, F1000Research.

[13]  Yuedong Wang,et al.  Lipid levels are inversely associated with infectious and all-cause mortality: international MONDO study results , 2018, Journal of Lipid Research.

[14]  Maojie Yang,et al.  Cholesterol negatively regulates IL-9–producing CD8+ T cell differentiation and antitumor activity , 2018, The Journal of experimental medicine.

[15]  Neng Zhu,et al.  Lipid metabolism and carcinogenesis, cancer development. , 2018, American journal of cancer research.

[16]  Wan-Uk Kim,et al.  Atherogenic dyslipidemia promotes autoimmune follicular helper T cell responses via IL-27 , 2018, Nature Immunology.

[17]  E. Pearce,et al.  Unraveling the Complex Interplay Between T Cell Metabolism and Function. , 2018, Annual review of immunology.

[18]  S. Crotty,et al.  Apolipoprotein AI prevents regulatory to follicular helper T cell switching during atherosclerosis , 2018, Nature Communications.

[19]  J. Klein-Seetharaman,et al.  Lipid bodies containing oxidatively truncated lipids block antigen cross-presentation by dendritic cells in cancer , 2017, Nature Communications.

[20]  Chenqi Xu,et al.  Cholesterol Metabolism in T Cells , 2017, Front. Immunol..

[21]  Laura G. Dubois,et al.  The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells , 2017, Nature Communications.

[22]  Dennis C. Ko,et al.  Human genetic variation in VAC14 regulates Salmonella invasion and typhoid fever through modulation of cholesterol , 2017, Proceedings of the National Academy of Sciences.

[23]  V. D’Agati,et al.  Cholesterol Accumulation in Dendritic Cells Links the Inflammasome to Acquired Immunity. , 2017, Cell metabolism.

[24]  D. Moody,et al.  CD1b-autoreactive T cells contribute to hyperlipidemia-induced skin inflammation in mice , 2017, The Journal of clinical investigation.

[25]  John P. Donnelly,et al.  Cholesterol levels and long-term rates of community-acquired sepsis , 2016, Critical Care.

[26]  J. Witztum,et al.  Cholesterol Accumulation in CD11c+ Immune Cells Is a Causal and Targetable Factor in Autoimmune Disease. , 2016, Immunity.

[27]  J. Merino,et al.  Modulation of autoimmune arthritis severity in mice by apolipoprotein E (ApoE) and cholesterol , 2016, Clinical and experimental immunology.

[28]  H. Bluyssen,et al.  STAT1 and IRF8 in Vascular Inflammation and Cardiovascular Disease: Diagnostic and Therapeutic Potential , 2016, International reviews of immunology.

[29]  G. Silecchia,et al.  Visceral fat adipocytes from obese and colorectal cancer subjects exhibit distinct secretory and ω6 polyunsaturated fatty acid profiles and deliver immunosuppressive signals to innate immunity cells , 2016, Oncotarget.

[30]  R. Lehner,et al.  Tumor-Induced Hyperlipidemia Contributes to Tumor Growth , 2016, Cell reports.

[31]  Wei Yang,et al.  Potentiating the antitumour response of CD8+ T cells by modulating cholesterol metabolism , 2016, Nature.

[32]  Pau-Chung Chen,et al.  Statin reduces mortality and morbidity in systemic lupus erythematosus patients with hyperlipidemia: A nationwide population-based cohort study. , 2015, Atherosclerosis.

[33]  J. Cook,et al.  Is higher serum cholesterol associated with altered tendon structure or tendon pain? A systematic review , 2015, British Journal of Sports Medicine.

[34]  A. Tall,et al.  Cholesterol, inflammation and innate immunity , 2015, Nature Reviews Immunology.

[35]  A. Nowak,et al.  Tumor‐infiltrating dendritic cells exhibit defective cross‐presentation of tumor antigens, but is reversed by chemotherapy , 2015, European journal of immunology.

[36]  M. Hallek,et al.  Inhibition of Protein Geranylgeranylation Specifically Interferes with CD40-Dependent B Cell Activation, Resulting in a Reduced Capacity To Induce T Cell Immunity , 2014, The Journal of Immunology.

[37]  M. Kuroda,et al.  C-type lectin-like receptor LOX-1 promotes dendritic cell-mediated class-switched B cell responses. , 2014, Immunity.

[38]  P. Yu,et al.  Suppression of vascular endothelial growth factor abrogates the immunosuppressive capability of murine gastric cancer cells and elicits antitumor immunity , 2014, The FEBS journal.

[39]  Y. Momiyama,et al.  Inflammation, Atherosclerosis and Coronary Artery Disease , 2014, Clinical Medicine Insights. Cardiology.

[40]  D. O'Shea,et al.  Changes in human dendritic cell number and function in severe obesity may contribute to increased susceptibility to viral infection , 2013, International Journal of Obesity.

[41]  Min Zhang,et al.  Antagonism of Betulinic Acid on LPS-Mediated Inhibition of ABCA1 and Cholesterol Efflux through Inhibiting Nuclear Factor-kappaB Signaling Pathway and miR-33 Expression , 2013, PloS one.

[42]  C. Sakamoto,et al.  Inactivation of tumor-specific CD8+ CTLs by tumor-infiltrating tolerogenic dendritic cells , 2013, Immunology and cell biology.

[43]  Peter Vogel,et al.  mTORC1 couples immune signals and metabolic programming to establish Treg cell function , 2013, Nature.

[44]  J. Rathmell,et al.  Metabolic regulation of T lymphocytes. , 2013, Annual review of immunology.

[45]  D. Legler,et al.  Converse regulation of CCR7‐driven human dendritic cell migration by prostaglandin E2 and liver X receptor activation , 2012, European journal of immunology.

[46]  Andrew C. Li,et al.  Regulated Accumulation of Desmosterol Integrates Macrophage Lipid Metabolism and Inflammatory Responses , 2012, Cell.

[47]  R. Lempicki,et al.  Retinoic acid and liver X receptor agonist synergistically inhibit HIV infection in CD4+ T cells by up-regulating ABCA1-mediated cholesterol efflux , 2012, Lipids in Health and Disease.

[48]  Sung-Hwan Park,et al.  Obesity aggravates the joint inflammation in a collagen-induced arthritis model through deviation to Th17 differentiation , 2012, Experimental & Molecular Medicine.

[49]  T. Strutt,et al.  Expanding roles for CD4+ T cells in immunity to viruses , 2012, Nature Reviews Immunology.

[50]  C. Weber,et al.  Atherosclerosis: current pathogenesis and therapeutic options , 2011, Nature Medicine.

[51]  C. Grundtman,et al.  The autoimmune concept of atherosclerosis , 2011, Current opinion in lipidology.

[52]  M. Ghazizadeh,et al.  Clinical Improvement in Psoriasis With Treatment of Associated Hyperlipidemia , 2011, The American journal of the medical sciences.

[53]  K. Moore,et al.  Macrophages in the Pathogenesis of Atherosclerosis , 2011, Cell.

[54]  G. Hansson,et al.  The immune system in atherosclerosis , 2011, Nature Immunology.

[55]  Kevin A. Robertson,et al.  Host Defense against Viral Infection Involves Interferon Mediated Down-Regulation of Sterol Biosynthesis , 2011, PLoS biology.

[56]  Guoliang Cui,et al.  Liver X receptor (LXR) mediates negative regulation of mouse and human Th17 differentiation. , 2011, The Journal of clinical investigation.

[57]  Egil Lien,et al.  NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals , 2010, Nature.

[58]  S. Gummuluru,et al.  PPARγ and LXR Signaling Inhibit Dendritic Cell-Mediated HIV-1 Capture and trans-Infection , 2010, PLoS pathogens.

[59]  T. Matsuo,et al.  Lipoproteins and CETP levels as risk factors for severe sepsis in hospitalized patients , 2010, European journal of clinical investigation.

[60]  K. Moore,et al.  CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer , 2009, Nature Immunology.

[61]  C. Hedrick,et al.  ATP-Binding Cassette Transporter G1 Negatively Regulates Thymocyte and Peripheral Lymphocyte Proliferation , 2009, The Journal of Immunology.

[62]  G. Kitas,et al.  Atherosclerosis in Rheumatoid Arthritis Versus Diabetes: A Comparative Study , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[63]  E. Engleman,et al.  Obesity predisposes to Th17 bias , 2009, European journal of immunology.

[64]  C. R. D. de Galarreta,et al.  Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. , 2009, Immunity.

[65]  M. Nurmohamed.  Cardiovascular risk in rheumatoid arthritis. , 2009, Autoimmunity reviews.

[66]  H. John,et al.  Cardiovascular co-morbidity in early rheumatoid arthritis. , 2009, Best practice & research. Clinical rheumatology.

[67]  A. Tall,et al.  Increased Inflammatory Gene Expression in ABC Transporter–Deficient Macrophages: Free Cholesterol Accumulation, Increased Signaling via Toll-Like Receptors, and Neutrophil Infiltration of Atherosclerotic Lesions , 2008, Circulation.

[68]  P. Libby,et al.  CD11c+ Dendritic Cells Maintain Antigen Processing, Presentation Capabilities, and CD4+ T-Cell Priming Efficacy Under Hypercholesterolemic Conditions Associated With Atherosclerosis , 2008, Circulation research.

[69]  P. Libby,et al.  The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models , 2008, Nature Reviews Immunology.

[70]  Peter Tontonoz,et al.  LXR Signaling Couples Sterol Metabolism to Proliferation in the Acquired Immune Response , 2008, Cell.

[71]  G. Martens,et al.  Hypercholesterolemia Impairs Immunity to Tuberculosis , 2008, Infection and Immunity.

[72]  L. Esserman,et al.  Estrogen Receptor–Negative Breast Cancer Is Less Likely to Arise among Lipophilic Statin Users , 2008, Cancer Epidemiology Biomarkers & Prevention.

[73]  A. Kimball,et al.  Cardiovascular Disease and Risk Factors among Psoriasis Patients in Two US Healthcare Databases, 2001–2002 , 2008, Dermatology.

[74]  S. Knight.  Specialized perinodal fat fuels and fashions immunity. , 2008, Immunity.

[75]  M. Thun,et al.  Cholesterol-Lowering Drugs and Advanced Prostate Cancer Incidence in a Large U.S. Cohort , 2007, Cancer Epidemiology Biomarkers & Prevention.

[76]  S. Gabriel,et al.  Heart disease in psoriasis. , 2007, Journal of the American Academy of Dermatology.

[77]  M. Säemann,et al.  Liver X receptors regulate dendritic cell phenotype and function through blocked induction of the actin-bundling protein fascin. , 2007, Blood.

[78]  D. Gabrilovich,et al.  Lipid Accumulation and Dendritic Cell Function in Cancer (49.10) , 2007, The Journal of Immunology.

[79]  L. Rohrer,et al.  Dyslipidemia inhibits Toll-like receptor–induced activation of CD8α-negative dendritic cells and protective Th1 type immunity , 2007, The Journal of experimental medicine.

[80]  C. Dong,et al.  Act1 Adaptor Protein Is an Immediate and Essential Signaling Component of Interleukin-17 Receptor* , 2006, Journal of Biological Chemistry.

[81]  Peter Libby,et al.  The immune response in atherosclerosis: a double-edged sword , 2006, Nature Reviews Immunology.

[82]  F. Nestle,et al.  Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial , 2005, The Lancet.

[83]  N. Goodson,et al.  Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s , 2005, Annals of the rheumatic diseases.

[84]  D. Gabrilovich.  Mechanisms and functional significance of tumour-induced dendritic-cell defects , 2004, Nature Reviews Immunology.

[85]  M. Netea,et al.  Apolipoprotein-E-deficient mice exhibit an increased susceptibility to disseminated candidiasis. , 2004, Medical mycology.

[86]  J. Schwartz,et al.  Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. , 2003, The New England journal of medicine.

[87]  G. Cheng,et al.  Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. , 2003, Molecular cell.

[88]  F. Granath,et al.  Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients , 2003, European Journal of Epidemiology.

[89]  P. Hwu,et al.  MHC class I and class II presentation of tumor antigen in retrovirally and adenovirally transduced dendritic cells , 2002, Cancer Gene Therapy.

[90]  R. Förster,et al.  Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. , 2002, Blood.

[91]  M. Abrahamowicz,et al.  Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. , 2001, Arthritis and rheumatism.

[92]  S. Ehlers,et al.  Inflammation and lymphocyte activation during mycobacterial infection in the interferon-gamma-deficient mouse. , 2001, Cellular immunology.

[93]  R. Zinkernagel,et al.  Hypercholesterolemia Exacerbates Virus-Induced Immunopathologic Liver Disease Via Suppression of Antiviral Cytotoxic T Cell Responses1 , 2001, The Journal of Immunology.

[94]  R. North,et al.  The Relative Importance of T Cell Subsets in Immunity and Immunopathology of Airborne Mycobacterium tuberculosis Infection in Mice , 2001, The Journal of experimental medicine.

[95]  I. Orme.  Immunology and vaccinology of tuberculosis: can lessons from the mouse be applied to the cow? , 2001, Tuberculosis.

[96]  D. Jacobs,et al.  Cohort study of serum total cholesterol and in-hospital incidence of infectious diseases , 1998, Epidemiology and Infection.

[97]  A. Daugherty,et al.  Apolipoprotein E-deficient mice have impaired innate immune responses to Listeria monocytogenes in vivo. , 1998, Journal of lipid research.

[98]  R. Evans,et al.  Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ , 1998, Cell.

[99]  R. D'Agostino,et al.  Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. , 1997, American journal of epidemiology.

[100]  A. Wahba-Yahav.  Disease concomitance in psoriasis. , 1996, Journal of the American Academy of Dermatology.

[101]  L. Naldi,et al.  Dietary factors and the risk of psoriasis. Results of an Italian case–control study , 1996, The British journal of dermatology.

[102]  R. Chakrabarti,et al.  Interrelationships between mevalonate metabolism and the mitogenic signaling pathway in T lymphocyte proliferation. , 1991, The Journal of biological chemistry.

[103]  J. Levy,et al.  Dietary fat and immune function. I. Antibody responses, lymphocyte and accessory cell function in (NZB x NZW)F1 mice. , 1985, Journal of immunology.

[104]  J. Levy,et al.  Dietary fat and immune function. II. Effects on immune complex nephritis in (NZB x NZW)F1 mice. , 1985, Journal of immunology.

[105]  A. Perl,et al.  The role of the low energy diet in psoriasis vulgaris treatment. , 2003, Collegium antropologicum.

[106]  D. Altshuler,et al.  The role of PPAR-gamma in macrophage differentiation and cholesterol uptake. , 2001, Nature medicine.

[107]  R. Evans,et al.  PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation , 2001, Nature Medicine.